Table 3.
DHEA/DHEAS | PTEN | |||||||
---|---|---|---|---|---|---|---|---|
16–20 years (n = 4) | 41–43 years (n = 3) | 16–20 years (n = 4) | 41–43 years (n = 3) | |||||
Positive | Total | Positive | Total | Positive | Totala | Positive | Totala | |
9 | 20 | 5 | 23 | 26 | 28 | 19 | 23 | |
18 | 24 | 9 | 20 | 31 | 35 | 21 | 24 | |
3 | 29 | 0 | 19 | 26 | 27 | 18 | 24 | |
23 | 23 | 2 | 28 | |||||
Mean | 13.25 | 24 | 4.66 | 20.66 | 21.25 | 29.5 | 19.33 | 23.66 |
±s.d. | 8.96 | 3.74 | 4.41 | 2.08 | 13.05 | 3.70 | 1.53 | 0.58 |
Total number (hematoxylin counterstained) subtracted by the number of positive cells for DHEA/DHEAS are negative cells for DHEA/DHEAS, and vice versa for PTEN. The comparisons were between younger adults (with higher blood DHEAS levels) and the age group with significant percent of cases <2040 nmol/L.
aP < 0.05.